Frank X. Leonard, Chief Development Officer at NovoCure Ltd (NVCR), sold 1,488 shares at $70.10 ($104K) on 2022-03-08, disclosed to the SEC on 2022-03-09.
Open-market sale of $104k NVCR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.10 | 744 | $52K | 50.0% |
| 2 | $70.10 | 744 | $52K | 50.0% |
| Total | $70.10 avg | 1,488 | $104K | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |